BlackRock’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-97
Closed -$10.8K 5325
2024
Q2
$10.8K Hold
97
﹤0.01% 5064
2024
Q1
$8.96K Hold
97
﹤0.01% 5099
2023
Q4
$7.45K Hold
97
﹤0.01% 5169
2023
Q3
$8.19K Hold
97
﹤0.01% 5216
2023
Q2
$17K Hold
97
﹤0.01% 5218
2023
Q1
$28.2K Hold
97
﹤0.01% 5212
2022
Q4
$109K Buy
+97
New +$80.4K ﹤0.01% 5019
2020
Q2
Hold
0
-$22K 5141
2020
Q1
Hold
0
4607
2019
Q4
Hold
0
4632
2019
Q3
Hold
0
4604
2019
Q2
Hold
0
4511
2019
Q1
Hold
0
4512
2018
Q4
Hold
0
4356

Other funds holding VTAK

BlackRock's VTAK Position: Q3 2024 in Review

BlackRock sold out of Catheter Precision (VTAK) in Q3 2024, closing a stake of 97 shares — an estimated $10.8K sold.

BlackRock first reported a position in VTAK in Q4 2022 and held it in 7 quarters. The position peaked at $109K in Q4 2022. 9 funds tracked by Wall St. Rank hold VTAK as of Q3 2024.

  • BlackRock reported no remaining Catheter Precision position as of Q3 2024 after selling out during the quarter.
  • BlackRock sold 97 Catheter Precision shares in Q3 2024, an estimated $10.8K.
  • BlackRock first reported a position in Catheter Precision in Q4 2022 and held it in 7 quarters.
  • BlackRock's Catheter Precision position peaked at $109K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2024.

Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.